SERI® Surgical Scaffold

facilitates neovascularization (as early as 2 days)1

SERI® Surgical Scaffold + Tissue1

SERI® Surgical Scaffold, along with newly ingrown tissue, was shown to exhibit neovascularization.1

Sericin is extracted from the fiber, leaving behind fibroin protein with minimal residual sericin1,4

The purified bioengineering process removes the sercin, leaving behind fibroin protein filament of ≥ 95% purity on average.1,3,4


Methodology: In a study using SERI® Surgical Scaffold in a rat model of abdominal wall defect, SERI® Surgical Scaffold plus tissue sample was taken after 4 weeks following implantation. In a separate rat model study, scar tissue sample was taken after 7 weeks following implantation and identified from the incision site.1
Note: Similar studies in humans have not been performed.


Bioreplaced
Over Time1,*
Learn more
Favorable
Biocompatibility1,*
Learn how our silk
is different
Support and Strength
from Native Tissue1,*
Learn more
Case
Reviews
See operative
techniques using SERI®

Indications for Use
SERI® Surgical Scaffold is indicated for use as a transitory scaffold for soft tissue support and repair to reinforce deficiencies where weakness or voids exist that require the addition of material to obtain the desired surgical outcome. This includes reinforcement of soft tissue in plastic and reconstructive surgery, and general soft tissue reconstruction.

Important Safety Information

Contraindications

  • Patients with a known allergy to silk
  • Contraindicated for direct contact with bowel or viscera where formation of adhesions may occur

Warnings

  • SERI® Surgical Scaffold must be placed in maximum possible contact with healthy well-vascularized tissue to encourage ingrowth and tissue remodeling
  • Caution should be used when implanting SERI® Surgical Scaffold in pregnant women. The use of a device that can impede tissue expansion may be hazardous during pregnancy

Adverse Reactions
Adverse reactions are those typically associated with surgically implantable materials, including infection, inflammation, adhesion formation, fistula formation, and extrusion.

Important
Before using SERI® Surgical Scaffold, read the Instructions for Use which accompany the product for full safety information. This can be found here.

Caution
Rx only.

*Methodology: In an ovine subcutaneous thoracic wall implant study designed to measure the strength and thickness of SERI® Surgical Scaffold and newly generated native tissue at up to 24 months after implantation of SERI®.1
Note: Similar studies in humans have not been performed.

†Methodology: In a study using SERI® Surgical Scaffold in a rat model of abdominal wall defect.1
Note: Similar studies in humans have not been performed.


Instructions for Use   |   Privacy Statement   |  

Terms of Use |   Terms of Sale     |  

Sofregen.com     |  

Contact Sofregen   |  

Site Map   |   References

©Sofregen Medical Inc., 200 Boston Ave, Suite 1100, Medford MA 02155 ® marks owned by Sofregen Medical Ireland LTD
  L-504 10.27.17